Infection Control & Hospital Epidemiology
20. Song X, Cheung S, Klontz K, Short B, Campos J, Singh N. A stepwise approach to control an outbreak and ongoing transmission of methicillin- resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Infect Control 2010;38:607–611.
21. Mathers AJ, Poulter M, Dirks D, Carroll J, Sifri CD, Hazen KC. Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Infect Control Hosp Epidemiol 2014;35:350–355.
22. Arhoune B, Oumokhtar B, Hmami F, et al. Rectal carriage of extended- spectrum beta-lactamase– and carbapenemase-producing Enterobacter- iaceae among hospitalised neonates in a neonatal intensive care unit in Fez, Morocco. J Glob Antimicrob Resist 2017;8:90–96.
23. Benenson S, Levin PD, Block C, et al. Continuous surveillance to reduce extended-spectrum beta-lactamase Klebsiella pneumoniae colonization in the neonatal intensive care unit. Neonatology 2013;103:155–160.
24. Harris AD, McGregor JC, Johnson JA, et al. Risk factors for colonization with extended-spectrum beta-lactamase–producing bac- teria and intensive care unit admission. Emerg Infect Dis 2007;13: 1144–1149.
1441
25. Verhoef J, Beaujean D, Blok H, et al. A Dutch approach to methicillin- resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999;18:461–466.
26. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin- resistant Enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427–1433.
27. Marshall C, Richards M, McBryde E. Do active surveillance and contact precautions reduce MRSA acquisition? A prospective interrupted time series. PLoS One 2013;8:e58112.
28. Evans ME, Kralovic SM, Simbartl LA, Jain R, Roselle GA. Eight years of decreased methicillin-resistant Staphylococcus aureus healthcare- associated infections associated with a Veterans Affairs prevention initiative. Am J Infect Control 2017;45:13–16.
29. Siegel JD, Rhinehart E, JacksonM,Chiarello L, Healthcare Infection Control Practices Advisory C. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control 2007;35:S165–S193.
30. Rybczynska H, Melander E, Johansson H, Lundberg F. Efficacy of a once- a-week screening programme to control extended-spectrum beta- lactamase–producing bacteria in a neonatal intensive care unit. Scand J Infect Dis 2014;46:426–432.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124
